Medicare Just Built the First Federal Payment System for AI Healthcare — 150 Companies Are Already In

This Is the Biggest Medicare Overhaul in a Decade. You Probably Missed It.

On July 5, 2026, a 10-year federal experiment goes live that could permanently change how Medicare pays for healthcare. It's called ACCESS — Advancing Chronic Care with Effective, Scalable Solutions — and according to CMS, 150 digital health companies have already been approved for the launch cohort.

Over 350 organizations submitted intent to apply.

What ACCESS Actually Does

Traditional Medicare pays doctors for time. A visit. A procedure. A checklist.

ACCESS throws that model out. Under the new structure, companies receive outcome-aligned payments — meaning they get full reimbursement only when patients hit measurable health targets. Lower blood pressure. Better diabetes control. Reduced chronic pain. Results, not paperwork.

For the first time, Medicare can pay an AI agent that monitors a patient between office visits, makes check-in calls, coordinates a housing referral, or confirms a prescription got picked up. None of that was reimbursable before. According to Prism News, CMS launched basic Chronic Care Management codes back in 2015 and added remote physiologic monitoring codes in 2019 and 2020 — but ACCESS goes significantly further by recognizing AI-supported longitudinal care across the board.

The program covers six conditions: hypertension, diabetes, chronic kidney disease, obesity, depression, and anxiety. More than two-thirds of all Medicare beneficiaries manage at least one of these conditions.

The Company That Saw This Coming

Neil Batlivala, CEO of Pair Team, has been building toward this moment since 2019. According to TechCrunch, Pair Team was accepted into the ACCESS launch cohort — one of 150 approved organizations — and focuses specifically on patients managing chronic conditions while also dealing with housing instability, food insecurity, or lack of transportation.

Pair Team now employs roughly 850 clinical professionals and runs what it describes as the largest community health workforce in California.

"The government is creating swim lanes for AI innovation in traditionally regulated industries," Batlivala told TechCrunch. "The best solution wins — which in regulated industries like healthcare, that's not been the case."

Batlivala is also skeptical of some fellow participants. He questioned how much value a Whoop wearable — yes, the fitness tracker is among the approved cohort — realistically delivers to a senior struggling with food insecurity. Whoop is a great product for optimizing an athlete's sleep cycle. It's a different conversation for a 72-year-old diabetic in a food desert.

Meanwhile: AI Is Also Being Deployed to STOP Medicare Waste

ACCESS isn't the only AI Medicare program running right now. CMS also launched the WISeR model — Wasteful and Inappropriate Service Reduction — which went live January 1, 2026.

WISeR runs for six years across six states: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. It uses AI and machine learning, combined with human clinical review, to catch Medicare billing for services that have little to no clinical evidence behind them.

The targets include skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy for osteoarthritis — all historically high-fraud, high-waste categories. According to CMS directly, waste accounts for up to 25% of all U.S. healthcare spending. That's hundreds of billions of dollars annually going to treatments that either don't work or don't apply to the patient receiving them.

WISeR essentially puts AI in the prior authorization seat. It's designed to flag bad claims faster, reduce administrative burden on providers who are doing things right, and protect taxpayers from being billed for junk medicine.

Smaller government and smarter spending working together appear in few federal programs. The combination is noteworthy.

What Mainstream Coverage Got Wrong

Most outlets that covered ACCESS at all treated it as a tech industry story — Silicon Valley getting a new playground. The story actually runs much deeper.

This is a payment model transformation. The regulatory structure that kept AI healthcare companies from getting paid is being dismantled. Private insurers covering 165 million Americans across Medicare Advantage, Medicaid, and commercial plans have already pledged to align with ACCESS-style outcome-based payments, according to Prism News. If this model works, it doesn't stay in Medicare. It goes everywhere.

WISeR received almost no mainstream coverage. A program designed to use AI to cut Medicare fraud and waste should interest fiscal conservatives and government accountability journalists alike.

The Catches

This isn't a blank check. To participate in ACCESS, organizations must be enrolled in Medicare Part B, meet licensure and privacy-security requirements, and designate a physician clinical director accountable for quality and compliance. The first cohort deadline was May 15, 2026. Late applicants can aim for a January 1, 2027 start.

The outcome-based payment model is also a double-edged sword. Companies that can't prove results don't get full payment. That's good accountability — but it means organizations serving the hardest patients, the ones with the worst social conditions and fewest resources, face the toughest path to full reimbursement. Batlivala's Pair Team knows this better than anyone.

What This Means for You

If you're on Medicare with hypertension, diabetes, kidney disease, or depression — which statistically describes most Medicare enrollees — AI-supported care is coming to your coverage. Whether that's a phone call from an automated agent, a monitoring device, or a care coordinator tracking your prescriptions, the infrastructure to pay for it now exists at the federal level.

For taxpayers: WISeR is designed to stop billions in wasteful and fraudulent Medicare billing using the same technology everyone else is racing to deploy.

For the tech industry: the payment barrier that killed hundreds of healthcare AI startups just got a door cut through it. One hundred fifty companies walked through it on day one.

Which ones actually improve people's health remains to be seen.